Learn More
Medchemexpress LLC Lerociclib (dihydrochloride) | 2097938-59-3 | 98.5% | 547.52 | 50 MG

Supplier: Medchemexpress LLC HY112272A50MG
Lerociclib dihydrochloride is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 1 nM and 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively.
- Induces a strong and sustained G1 arrest in CDK4/6 dependent cells.
- Inhibits RB phosphorylation within 1 hour post-treatment.
- Effectively inhibits proliferation in various tumor cell lines including breast, melanoma, leukemia, and lymphoma.
- Shows tumor regression in HER2+ breast cancer models.
- Demonstrates tumor growth inhibition in NSCLC tumor models.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.